X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14) 14
humans (13) 13
female (12) 12
male (12) 12
aged (10) 10
endocrinology & metabolism (10) 10
risk factors (10) 10
middle aged (9) 9
diabetes (8) 8
diabetes mellitus, type 2 - complications (6) 6
cardiovascular diseases (5) 5
diabetes mellitus (5) 5
mortality (5) 5
type 2 diabetes (5) 5
abridged index medicus (4) 4
adult (4) 4
cohort studies (4) 4
complications and side effects (4) 4
diabetes mellitus, type 2 - drug therapy (4) 4
diabetes mellitus, type 2 - genetics (4) 4
diabetes mellitus, type 2 - mortality (4) 4
diabetics (4) 4
france - epidemiology (4) 4
glomerular filtration rate (4) 4
health risks (4) 4
hypertension (4) 4
kidney diseases (4) 4
patient outcomes (4) 4
patients (4) 4
research (4) 4
treatment outcome (4) 4
cardiac & cardiovascular systems (3) 3
cardiovascular disease (3) 3
care and treatment (3) 3
coronary-artery-disease (3) 3
diabetes mellitus, type 2 - blood (3) 3
diabetic nephropathies - epidemiology (3) 3
genetic aspects (3) 3
genotype (3) 3
health aspects (3) 3
health risk assessment (3) 3
heart attacks (3) 3
hypoglycemic agents (3) 3
hypoglycemic agents - therapeutic use (3) 3
original investigation (3) 3
population (3) 3
prevalence (3) 3
prognosis (3) 3
risk (3) 3
all-cause mortality (2) 2
amputation (2) 2
angioplasty (2) 2
arginine-vasopressin (2) 2
atherosclerosis (2) 2
atp-binding cassette transporters - genetics (2) 2
blood pressure (2) 2
cholesterol (2) 2
classification (2) 2
clinical medicine (2) 2
complications (2) 2
copeptin (2) 2
coronary disease - genetics (2) 2
diabetes mellitus, type 1 - blood (2) 2
diabetes mellitus, type 2 - diagnosis (2) 2
diabetes mellitus, type 2 - epidemiology (2) 2
diabetic angiopathies - etiology (2) 2
diabetic angiopathies - mortality (2) 2
diabetic nephropathies (2) 2
diabetic nephropathies - genetics (2) 2
diabetic retinopathy (2) 2
disease (2) 2
disease progression (2) 2
diseases of the circulatory system (2) 2
drug combinations (2) 2
epidemiology (2) 2
follow-up studies (2) 2
gene (2) 2
genetic polymorphisms (2) 2
glucose (2) 2
glucose control (2) 2
glycopeptides - blood (2) 2
impact (2) 2
incidence (2) 2
indapamide - therapeutic use (2) 2
infarction (2) 2
insulin glargine (2) 2
insulin, long-acting - therapeutic use (2) 2
internal medicine (2) 2
kidney function tests (2) 2
life sciences (2) 2
medicine (2) 2
medicine, general & internal (2) 2
myocardial infarction (2) 2
obesity (2) 2
perindopril - therapeutic use (2) 2
polymorphism, single nucleotide (2) 2
prevention (2) 2
progression (2) 2
proportional hazards models (2) 2
prospective studies (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9825, pp. 1489 - 1497
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2015, Volume 10, Issue 9, pp. e0137733 - e0137733
Journal Article
Cardiovascular Diabetology, ISSN 1475-2840, 07/2017, Volume 16, Issue 1, pp. 95 - 95
Journal Article
Cardiovascular Diabetology, ISSN 1475-2840, 09/2016, Volume 15, Issue 1, pp. 129 - 129
Journal Article
Metabolism, ISSN 0026-0495, 2015, Volume 64, Issue 6, pp. 713 - 719
Journal Article
Journal Article
Cardiovascular Diabetology, ISSN 1475-2840, 08/2018, Volume 17, Issue 1, pp. 110 - 110
Background: Cardiovascular disease and kidney damage are tightly associated in people with type 2 diabetes. Experimental evidence supports a causal role for... 
Type 2 diabetes | Cardiovascular disease | Epidemiology | Vasopressin | Copeptin | Diabetic kidney disease | CARDIAC & CARDIOVASCULAR SYSTEMS | GLOMERULAR-FILTRATION | RENAL-FUNCTION | ISCHEMIC-HEART-DISEASE | PROGNOSTIC VALUE | ALL-CAUSE MORTALITY | FUNCTION DECLINE | ARGININE-VASOPRESSIN | INSULIN-RESISTANCE | ENDOCRINOLOGY & METABOLISM | SURROGATE MARKER | CORONARY-ARTERY-DISEASE | Prognosis | Humans | Middle Aged | Male | Diabetic Nephropathies - blood | Diabetic Nephropathies - diagnosis | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Time Factors | Cardiovascular Diseases - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Cardiovascular Diseases - diagnosis | France - epidemiology | Risk Factors | Biomarkers - blood | Disease Progression | Diabetic Nephropathies - mortality | Diabetes Mellitus, Type 2 - diagnosis | Diabetes Mellitus, Type 2 - blood | Diabetes Mellitus, Type 2 - mortality | Glycopeptides - blood | Aged | Diabetic Nephropathies - epidemiology | Myocardial infarction | Heart attacks | Sex | Tobacco smoking | Risk | Congestive heart failure | Confidence intervals | Population | Blood pressure | Diabetes mellitus (non-insulin dependent) | Lipoproteins (high density) | Heart failure | Hypertension | Kidneys | Statistical analysis | Epidermal growth factor receptors | Diabetes mellitus | Mortality | Health risks | Triglycerides | Hazards | Regression analysis | Metabolism | Patients | Morbidity | Cholesterol | Glomerular filtration rate | Tobacco | Body mass | Insulin resistance | Infarction | Diabetes | Kidney diseases | Cardiovascular diseases | Health risk assessment | Smoking | Index Medicus
Journal Article
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 2012, Volume 167, Issue 4, pp. 1380 - 1384
Abstract Objective Assess the cardiovascular safety of Thiazolidinediones (TZD) in routine clinical practice. Background TZD are insulin-sensitizing... 
Cardiovascular | Diabetes | Registry | Mortality | Thiazolidinedione | Cardiovascular risk | Diabetics | Medical research | Patient outcomes | Medicine, Experimental | Hypoglycemic agents | Risk factors | Heart attack
Journal Article